Larimar Therapeutics, Inc. (LRMR) Total Assets by Year
Larimar Therapeutics, Inc. closed fiscal year 2025 with $145.8M in total assets, $67.8M in total liabilities and $78.1M in shareholder equity. This represents a decrease of 27.2% from the prior fiscal year. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters Larimar Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
LRMR Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25DEF 14A | FY24DEF 14A | FY23DEF 14A | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $145.8M-27.2% | $200.2M+108.7% | $95.9M-24.1% | $126.4M+60.7% | $78.7M-24.9% | $104.7M+1912.8% | $5.2M-95.7% | $121.8M+15.4% | $105.5M-19.8% | $131.6M-30.4% | $189.1M+60.9% | $117.5M+208.1% | $38.1M | N/A |
| Total Liabilities | $67.8M+138.5% | $28.4M+99.9% | $14.2M-8.3% | $15.5M+8.8% | $14.3M-4.9% | $15.0M+154.4% | $5.9M-95.0% | $118.8M+335.5% | $27.3M+175.9% | $9.9M-50.5% | $20.0M+52.9% | $13.1M-87.7% | $106.7M | N/A |
| Total Equity | $78.1M-54.6% | $171.8M+110.2% | $81.7M-26.3% | $110.9M+72.2% | $64.4M-28.2% | $89.7M+13023.9% | -$694K-123.8% | $2.9M-96.3% | $78.2M-35.7% | $121.7M-28.0% | $169.1M+61.9% | $104.4M+252.3% | -$68.6M-25.3% | -$54.7M |
LRMR Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $165.3M+10.2% | $208.5M+22.5% | $145.8M-27.2% | $187.3M-14.5% | $150.0M-36.8% | $170.2M-31.4% | $200.2M+108.7% | $219.0M+110.7% | $237.2M+112.3% | $248.2M+108.7% | $95.9M-24.1% | $104.0M-21.8% |
| Total Liabilities | $37.9M+25.8% | $50.5M+94.9% | $67.8M+138.5% | $48.3M+134.3% | $30.1M+17.0% | $25.9M+49.2% | $28.4M+99.9% | $20.6M+83.5% | $25.8M+118.5% | $17.4M+37.1% | $14.2M-8.3% | $11.2M-21.7% |
| Total Equity | $127.4M+6.3% | $158.0M+9.5% | $78.1M-54.6% | $139.0M-29.9% | $119.9M-43.3% | $144.3M-37.5% | $171.8M+110.2% | $198.4M+114.0% | $211.4M+111.6% | $230.8M+117.3% | $81.7M-26.3% | $92.7M-21.9% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Larimar Therapeutics, Inc. financials
Frequently Asked Questions
What was Larimar Therapeutics, Inc.'s total assets in fiscal year 2025?
Larimar Therapeutics, Inc. closed fiscal year 2025 with $145.8M in total assets, $67.8M in total liabilities and $78.1M in shareholder equity.
How fast is Larimar Therapeutics, Inc.'s total assets growing?
Larimar Therapeutics, Inc. (LRMR) total assets fell by 27.2% year over year, from $200.2M to $145.8M in fiscal year 2025.
What was Larimar Therapeutics, Inc.'s total assets in the most recent quarter?
Larimar Therapeutics, Inc. (LRMR) reported $165.3M in total assets in Q2 2026. This represents an increase of 10.2% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Larimar Therapeutics, Inc. (LRMR) reported on that line in every period on record.